James Tananbaum

GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA.

Amerigroup Corp. provides health care coverage to people eligible for medicaid and children insurance program benefits. The company was founded by Jeffrey L. McWaters on December 9,1994 and is headquartered in Virginia Beach, VA.

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. The firm's team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.

ROXRO Pharma, Inc. develops hospital strength acute pain products. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine; and SPRIX nasal spray for the short-term management of acute moderate to moderately severe pain that requires analgesia at the opioid level. The company was founded by Michael E Fitzgerald, Roger Whiting and Roberto Pedro Rosenkranz in 1999 and is headquartered in Menlo Park, CA.

Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA

WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA.

Prospect Management LLC is an independent hedge fund manager headquartered in Rochester, New York. The firm manages the Prospect Fund, a proprietary investment fund.

Sequenta, Inc. operates as a biotech company which discovers and develops clinical diagnostics based on immune system status. It develops molecular diagnostic assays based on a sequencing approach to the profiling of T and B cell receptor repertoires. The firm also provides sequencing-based test for minimal residual disease for leukemia and lymphoma. The company was founded by Thomas D. Willis and Malek Faham in 2007 and is headquartered in South San Francisco, CA.

DNAnexus, Inc. develops a cloud-based data analysis and management platform for DNA sequence data. It engages in the provision of cloud-based solutions for large-scale Deoxyribonucleic acid (DNA) data management and analysis. The firm offers a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The company was founded by Serafim Batzoglou, Andreas Sundquist and Arend Sidow in 2009 and is headquartered in Mountain View, CA.

Sierra Ventures, Inc (Sierra Ventures) is a venture capital firm founded in 1982 by Peter Wendell. The firm is headquartered in San Mateo, California.

Shaklee Global Group, Inc. engages in the manufacture and sale of nutritional supplements, home care, and personal care products. It operates through the following geographical segments: Japan, North America, and Other Asia. The company was founded on May 2, 1975 and is headquartered in Tokyo, Japan.

Patient Care, Inc. provides home health care services from disease management programs to private duty nursing. It also offers special programs such as wound care, cardiopulmonary, orthopedics and behavioral health. The company operates 27 branches in metropolitan areas throughout the Eastern and mid-Western states. Patient Care was founded in 1975 by Larry Sosnow and is headquartered in West Orange, NJ

Prospect Venture Partners (Prospect Venture Partners) is a venture capital firm founded in 1997 by Alexander E. Barkas and David Schnell. The firm is headquartered in Palo Alto, California.

Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA.

Predicant Biosciences, Inc. is a life sciences company, which used to develop minimally invasive technology for identifying and assaying protein biomarker patterns that reflect and differentiate biological states. It was founded in 2002 and was located in San Francisco, CA

Pathwork Diagnostics Inc. develops and delivers molecular diagnostics for oncology. The company was founded by Glenda Anderson, Richard Zare, and George M. Whitesides in 2003 and is headquartered in Redwood City, CA.

Young Presidents' Organization, Inc. is a global leadership community of over 30,000 chief executives from 142 countries. The non-profit company is based in Irving, TX and has a global presence of subsidiaries in several regions. The company's mission is to help its members become better leaders and better people. The company was founded in 1950 by Ray Hickok, Khalid Mohamed Jassem Kanoo. Thayer Smith has been the CEO of the company since 2007.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

PathWorks, Inc. operates as merchandise brokerage company. The company was founded on December 24, 2001 and is headquartered in Corvallis, OR.

Fabric Genomics, Inc. operates as an analytical genome interpretation company. It develops scalable and fully integrated informatics systems specifically design to interpret human genome sequences for research and clinical applications. The company was founded by by Martin G. Reese, Edward S. Kiruluta, John Stuelpnagel, and Paul Billings and is headquartered in Oakland, CA.

Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA.

Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco.

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.

Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom.

Healthverity, Inc. engages in developing technologies and software tools. Its solutions include healthverity census, marketplace, cipher, and consent. The company was founded by Andrew Goldberg and Andrew Kress in 2014 and is headquartered in Philadelphia, PA.

LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA.

Mindstrong, Inc. engages in the provision of behavioral and neuropsychiatric healthcare services. It develops a biomarker panel that measures brain function from interaction patterns captured passively and continuously from human-computer interfaces found in ubiquitous mobile technology. The company was founded by Paul Dagum, Thomas R. Insel, and Rick Klausner in 2014 and is headquartered in Palo Alto, CA.

Evonetix Ltd. is a biotechnology company. The firm offers pharmaceuticals and drug discovery, industrial biotech and renewables, materials science, agriculture, digital data storage, and food and beverages. The company was founded by Hermann Maria Hauser and Joseph Brennan in 2015 and is headquartered in Little Chesterford, the United Kingdom.

Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA.

Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company was founded by Molly He and is headquartered in San Diego, CA.

Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.

Eikon Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Hayward, CA.

Detect, Inc. is a medical device and biotechnology company. The company was founded by Jonathan Rothberg and is headquartered in Guilford, CT.

FS Development Corp. operates as a blank check company. It is for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Jim Tananbaum in June 2020 and is headquartered in San Francisco, CA.

FS Development Corp. II is a blank check company, which formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more entities. The company was founded by James B. Tananbaum on August 21, 2020 and is headquartered in Larkspur, CA.

Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA.

Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA.

Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021.

Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA.

Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The private company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters.